Biomarkers in Immunotherapy of Melanoma

Clinical trial NCT05878977 · RECRUITING

Trial details

NCT number: NCT05878977
Sponsor: Institute of Oncology Ljubljana
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Metastatic Melanoma Immune Checkpoints Inhibitors Gastrointestinal Microbiome (Bacterial and Viral)Exosomal mRNA Expression of PD-L1 and IFNγ

Start date: 2022-10-05
Primary completion: 2026-12-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.